当前位置:首页 - 行情中心 - 海王生物(000078) - 财务分析 - 现金流量表

海王生物

(000078)

  

流通市值:65.40亿  总市值:65.51亿
流通股本:26.26亿   总股本:26.31亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金21,610,150,615.0414,100,111,719.337,064,334,275.2134,506,994,702.7
  收到的税费返还4,040,081.113,885,538.77221,332.72764,515.96
  收到其他与经营活动有关的现金2,315,189,162.32,126,537,819.211,345,335,528.92,429,015,566.72
  经营活动现金流入小计23,929,379,858.4516,230,535,077.318,409,891,136.8336,936,774,785.38
  购买商品、接受劳务支付的现金19,579,214,163.8512,115,217,351.236,058,772,313.0231,554,444,677.26
  支付给职工以及为职工支付的现金721,337,872.61493,335,319.32268,541,180.571,020,405,486.9
  支付的各项税费442,951,779.17311,966,805.19148,439,657.33718,624,669.72
  支付其他与经营活动有关的现金3,146,172,382.673,251,934,203.91,886,706,674.723,603,760,143.24
  经营活动现金流出小计23,889,676,198.316,172,453,679.648,362,459,825.6436,897,234,977.12
  经营活动产生的现金流量净额39,703,660.1558,081,397.6747,431,311.1939,539,808.26
二、投资活动产生的现金流量:
  收回投资收到的现金30,918,464.4519,582,769.9219,356,592.58868,063,284.61
  取得投资收益收到的现金2,692,041.67688,000643,317.457,333,555.56
  处置固定资产、无形资产和其他长期资产收回的现金净额5,970,605.255,219,607.532,392,759.187,622,706.24
  处置子公司及其他营业单位收到的现金净额12,430,730.396,703,608.79-13,986,533.78
  收到的其他与投资活动有关的现金---552,100
  投资活动现金流入小计52,011,841.7632,193,986.2422,392,669.21897,558,180.19
  购建固定资产、无形资产和其他长期资产支付的现金112,201,354.4286,544,612.3962,522,838.4684,601,674.2
  投资支付的现金28,640,70320,036,90316,030,703909,225,289.33
  取得子公司及其他营业单位支付的现金---43,959,190.71
  支付其他与投资活动有关的现金--15,665,259.51-
  投资活动现金流出小计140,842,057.42106,581,515.3994,218,800.971,037,786,154.24
  投资活动产生的现金流量净额-88,830,215.66-74,387,529.15-71,826,131.76-140,227,974.05
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,000,0002,000,0002,000,00017,000,000
  其中:子公司吸收少数股东投资收到的现金2,000,0002,000,0002,000,00017,000,000
  取得借款收到的现金6,537,929,240.863,542,058,226.072,442,308,798.9610,812,039,695.55
  收到其他与筹资活动有关的现金6,312,635,327.234,642,733,105.342,703,972,985.379,138,843,937.51
  筹资活动现金流入小计12,852,564,568.098,186,791,331.415,148,281,784.3319,967,883,633.06
  偿还债务支付的现金6,072,850,474.743,577,221,874.52,408,941,811.6312,257,193,276.78
  分配股利、利润或偿付利息支付的现金470,361,973.42297,405,156.48136,646,141.91697,349,346.6
  其中:子公司支付给少数股东的股利、利润144,127,709.0875,886,964.3528,347,366.78190,709,540.02
  支付其他与筹资活动有关的现金6,938,546,679.14,443,393,282.152,866,013,452.86,776,787,950.66
  筹资活动现金流出小计13,481,759,127.268,318,020,313.135,411,601,406.3419,731,330,574.04
  筹资活动产生的现金流量净额-629,194,559.17-131,228,981.72-263,319,622.01236,553,059.02
四、汇率变动对现金及现金等价物的影响-359.1-359.1--
五、现金及现金等价物净增加额-678,321,473.78-147,535,472.3-287,714,442.58135,864,893.23
  加:期初现金及现金等价物余额1,272,594,941.511,272,594,941.511,272,594,941.511,136,730,048.28
  期末现金及现金等价物余额594,273,467.731,125,059,469.21984,880,498.931,272,594,941.51
补充资料:
  净利润-64,822,903.73--1,167,311,201.03
  资产减值准备--2,809,693.07-811,871,188.17
  固定资产和投资性房地产折旧-49,189,245.02-133,572,829.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-49,189,245.02-133,572,829.85
  无形资产摊销-17,573,339.63-34,174,183.8
  长期待摊费用摊销-10,146,980.15-20,234,067.04
  处置固定资产、无形资产和其他长期资产的损失-173,310.51--6,808,511.29
  固定资产报废损失---0
  公允价值变动损失--70,959.24--6,384,310.59
  财务费用-297,658,906.22-808,767,253.27
  投资损失--88,840,372.84--11,147,013.77
  递延所得税-24,024,244.76--51,994,768.44
  其中:递延所得税资产减少-24,457,207.18--51,128,090.56
    递延所得税负债增加--432,962.42--866,677.88
  存货的减少-128,671,270.01-163,279,414.2
  经营性应收项目的减少--316,381,161.99-554,789,797.68
  经营性应付项目的增加--157,300,329.87--1,321,199,871.11
  其他---0
  不涉及现金收支的投资和筹资活动金额其他项目---71,080,431.63
  现金的期末余额-1,125,059,469.21-1,272,594,941.51
  减:现金的期初余额-1,272,594,941.51-1,136,730,048.28
  现金及现金等价物的净增加额--147,535,472.3-135,864,893.23
公告日期2025-10-302025-08-302025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑